Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Ovarian cancer and related topics: MedlinePlus Genetics were added to the glossary/related topics, and the revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T04:41:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2. The related topics block was shortened by removing items such as Ovarian cancer and MedlinePlus Genetics, along with the older Revision: v3.6.0 entry.
    Difference
    0.2%
    Check dated 2026-06-27T23:47:31.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Enrollment status now shows no recruitment. The page adds new user guidance sections and standardizes labeling, accompanied by a site version update.
    Difference
    0.4%
    Check dated 2026-06-13T17:35:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a subsequent editorial/technical update to the record without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-06-06T13:40:49.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Adds ovarian cancer as a condition tag and introduces related topics including MedlinePlus Genetics to the study page, improving discoverability and linking to background resources.
    Difference
    0.2%
    Check dated 2026-05-30T12:03:55.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Ovarian cancer and the related topics: MedlinePlus Genetics have been removed from the page, reducing explicit disease tagging and related topics navigation.
    Difference
    0.2%
    Check dated 2026-05-23T10:22:01.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.